BIOQUELL, Inc.
BIOQUELL, Inc., a leader in the field of infection control and bio-decontamination, is headquartered in the United States. Founded in 1997, the company has established itself as a key player in the healthcare and pharmaceutical industries, providing innovative solutions to combat harmful pathogens. BIOQUELL is renowned for its unique hydrogen peroxide vapour technology, which offers effective sterilisation and decontamination services. This advanced approach not only ensures compliance with stringent regulatory standards but also enhances patient safety in critical environments. With a strong market position, BIOQUELL has achieved significant milestones, including partnerships with major healthcare institutions and recognition for its contributions to infection prevention. The company continues to expand its operational reach, serving clients across North America and beyond, solidifying its reputation as a trusted provider in the bio-decontamination sector.
DitchCarbon Score
How does BIOQUELL, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
BIOQUELL, Inc.'s score of 90 is higher than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
BIOQUELL, Inc., headquartered in the US, currently does not report specific carbon emissions data for the most recent year, as no emissions figures are available. The company is a current subsidiary of Ecolab Inc., which influences its climate commitments and emissions reporting. While BIOQUELL, Inc. does not have its own documented reduction targets, it inherits sustainability initiatives and targets from Ecolab Inc. This includes participation in various climate initiatives such as the Science Based Targets initiative (SBTi), CDP, and RE100, all of which are cascaded from Ecolab Inc. at a corporate family level. These initiatives reflect a commitment to reducing carbon emissions and transitioning to renewable energy sources. As part of Ecolab Inc.'s broader climate strategy, BIOQUELL, Inc. aligns with industry standards for sustainability and climate action, although specific targets and achievements for BIOQUELL, Inc. are not detailed. The company is positioned within a framework that prioritises environmental responsibility and aims to contribute to global climate goals through its parent organisation's initiatives.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 396,916,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 289,712,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | 6,919,965,000 | 0,000,000,000 | 0,000,000,000 | - | 0,000,000,000 | - | - | 0,000,000,000 | 0,000,000,000 | 0,000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
BIOQUELL, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
